OTC makers see slower sales growth

Published: 2008-03-18 06:56:00

Updated: 2008-03-18 06:56:00

A red light is on for the nation's OTC makers as their flagship products are not sold as expected earlier, although medicinal plasters have been excluded from the insurance list since last month.

"We cannot paint a rosy picture on the sales of leading OTC products for the time being due to ext...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK